Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
- 1 February 2010
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (2) , 220-228
- https://doi.org/10.1097/jto.0b013e3181c814e7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsJournal of Clinical Oncology, 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Postoperative Chemotherapy in Nonsmall Cell Lung Cancer: A Systematic ReviewThe Annals of Thoracic Surgery, 2006
- Adjuvant Chemotherapy for Non–Small Cell Lung Cancer: Contribution of the International Adjuvant Lung TrialClinical Cancer Research, 2005
- Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literatureLung Cancer, 2005
- The ALPI Trial: The Italian/European Experience with Adjuvant Chemotherapy in Resectable Non–Small Lung CancerClinical Cancer Research, 2005
- Role of Adjuvant Chemotherapy in Patients With Resected Non–Small-Cell Lung Cancer: Reappraisal With a Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Oncology, 2004
- Postoperative chemotherapy for non–small cell lung cancer: A systematic review and meta-analysisThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1European Journal of Cardio-Thoracic Surgery, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002